300358.SZ
楚天科技
SZSE · Healthcare · C 制造业 · CN
CNY 8.67
−3.67%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 5.8B | 5.8B | 5.8B | 6.9B | 6.4B |
| Cost of Revenue | 3.8B | 3.9B | 4.3B | 4.7B | 4.1B |
| Gross Profit | 2.0B | 1.9B | 1.5B | 2.2B | 2.3B |
| Operating Expenses | |||||
| R&D Expense | 508.3M | 484.8M | 625.5M | 587.8M | 539.2M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 463.5M | 472.0M | 516.3M | 470.5M | 400.4M |
| Selling & Marketing Expense | 593.2M | 597.2M | 608.0M | 690.3M | 765.7M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 1.7B | 1.7B | 1.9B | 1.9B | 1.8B |
| Cost and Expenses | 5.5B | 5.6B | 6.2B | 6.5B | 5.9B |
| Operating Income (EBIT) | 342.0M | 259.1M | (561.3M) | 327.0M | 606.5M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | 328.5M | 247.6M | (575.4M) | 304.8M | 585.5M |
| Income Tax Expense | 2.2M | (1.1M) | (115.2M) | (6.3M) | 13.5M |
| Bottom Line | |||||
| Net Income | 331.0M | 254.7M | (452.7M) | 317.1M | 567.4M |
| Earnings from Cont. Ops | 326.3M | 248.7M | (460.3M) | 311.1M | 572.0M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 331.0M | 254.7M | (452.7M) | 317.1M | 567.4M |
| Per Share | |||||
| Basic EPS | CN¥0.54 | CN¥0.43 | (CN¥0.77) | CN¥0.55 | CN¥0.99 |
| Diluted EPS | CN¥0.54 | CN¥0.43 | (CN¥0.77) | CN¥0.55 | CN¥0.97 |
| Revenue Per Share | CN¥8.02 | CN¥9.65 | CN¥9.88 | CN¥11.81 | CN¥11.21 |
| Shares | |||||
| Basic Shares Outstanding | 722.1M | 597.1M | 590.3M | 580.1M | 575.0M |
| Diluted Shares Outstanding | 722.1M | 597.1M | 590.3M | 580.1M | 575.0M |
| Profitability Metrics | |||||
| EBITDA | — | 534.3M | (303.0M) | 560.6M | 812.7M |
| D&A | — | 275.1M | 258.4M | 233.5M | 206.2M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026